Fact based stock research
Baxter (NYSE:BAX)

Baxter stock research in summary

Baxter shares are more expensive than other comparable stocks. While they show above average growth, they are riskily financed, and are poor value. We recommend evaluating whether the future of the company Baxter is really as positive as the high price of the shares suggests. If you come to the conclusion that the future for this company is only average, that could be a reason to sell this share.

Latest Obermatt Ranks


Value Rank	32
Growth Rank	51
Safety Rank	49
Combined Rank	34

Country	USA
Industry	Health Care Equipment
Index	D.J. US Medical Equipment, S&P 500
Size class	X-Large

December 6, 2019. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist

Filter Similar Stocks

Similar Top 10

☀ Achievements

Top 10 Stock	Climate Protection Stock
Sound Incentives

Google: Baxter

News	Videos
Wikipedia about Baxter	Management
Employee Satisfaction	Customer Satisfaction

Research History: Baxter

RESEARCH HISTORY	2016	2017	2018	2019
VALUE
VALUE	74	33	33	32
GROWTH
GROWTH	63	60	28	51
SAFETY
SAFETY	85	78	79	49
COMBINED
COMBINED	97	65	51	34

Last update of Combined Rank: 6-Dec-2019. Financial reporting date used for calculating ranks: 30-Jun-2019. Stock research history is based on the Obermatt Method. The higher the rank, the better Baxter is in the corresponding investment strategy.

Value Metrics in Detail

VALUE METRICS	2016	2017	2018	2019
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S)	67	53	49	43
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E)	98	38	42	59
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book)	37	31	25	25
DIVIDEND YIELD
DIVIDEND YIELD	46	48	45	41
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE	74	33	33	32

Last update of Value Rank: 6-Dec-2019. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Baxter; except for dividend yield where the rank is higher, the higher the yield.

Growth Metrics in Detail

GROWTH METRICS	2016	2017	2018	2019
REVENUE GROWTH
REVENUE GROWTH	36	30	30	20
PROFIT GROWTH
PROFIT GROWTH	24	24	21	65
STOCK RETURNS
STOCK RETURNS	76	87	64	53
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH	63	60	28	51

Last update of Growth Rank: 30-Jun-2019. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Baxter.

Safety Metrics in Detail

SAFETY METRICS	2016	2017	2018	2019
LEVERAGE
LEVERAGE	73	77	76	60
REFINANCING
REFINANCING	44	46	47	49
LIQUIDITY
LIQUIDITY	85	77	74	54
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY	85	78	79	49

Last update of Safety Rank: 29-Nov-2019. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Baxter and the more cash is available to service its debt.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Baxter from December 6, 2019.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.